DIA EMEA: Research in Europe “Disconnected from Business”

In this Global Forum podcast, Dr. Holger G. Adelmann, Senior Vice President/Managing Director for DIA EMEA (Europe, Middle East & Africa), explains the background and vision for DIA BioVenture Day,  a new platform connecting stakeholders key to the success of bioventures and investigating if the current bioventure paradigm delivers equitable return for patients, investors, and health care systems, in Europe. “Several IPOs are currently happening in the US, and we have only a handful of mature biotechs in Europe,” Dr. Adelmann explains. “Why is that so? What prevents more biotechs from maturing and doing their final IPO in Europe?” Learn more about these topics at our Value & Regulatory Strategy Workshop in Europe.